1. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9992 (1st August 2015) Authors: Gnant, Michael; Pfeiler, Georg; Dubsky, Peter C; Hubalek, Michael; Greil, Richard; Jakesz, Raimund; Wette, Viktor; Balic, Marija; Haslbauer, Ferdinand; Melbinger, Elisabeth; Bjelic-Radisic, Vesna; Artner-Matuschek, Silvia; Fitzal, Florian; Marth, Christian; Sevelda, Paul; Mlineritsch, Brigitte; S... Journal: Lancet Issue: Volume 386:Issue 9992(2015) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Issue 9992 (1st August 2015) Authors: Gnant, Michael; Pfeiler, Georg; Dubsky, Peter C; Hubalek, Michael; Greil, Richard; Jakesz, Raimund; Wette, Viktor; Balic, Marija; Haslbauer, Ferdinand; Melbinger, Elisabeth; Bjelic-Radisic, Vesna; Artner-Matuschek, Silvia; Fitzal, Florian; Marth, Christian; Sevelda, Paul; Mlineritsch, Brigitte; S... Journal: Lancet Issue: Volume 386:Issue 9992(2015) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 3 (March 2019) Authors: Gnant, Michael; Pfeiler, Georg; Steger, Günther G; Egle, Daniel; Greil, Richard; Fitzal, Florian; Wette, Viktor; Balic, Marija; Haslbauer, Ferdinand; Melbinger-Zeinitzer, Elisabeth; Bjelic-Radisic, Vesna; Jakesz, Raimund; Marth, Christian; Sevelda, Paul; Mlineritsch, Brigitte; Exner, Ruth; Fesl, ... Journal: Lancet oncology Issue: Volume 20:Issue 3(2019) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). (June 2020) Authors: Singer, Christian F.; Pfeiler, Georg; Hubalek, Michael; Bartsch, Rupert; Stöger, Herbert; Pichler, Angelika; Petru, Edgar; Bjelic-Radisic, Vesna; Greil, Richard; Rudas, Margaretha; Maria Tea, Muy-Kheng; Wette, Viktor; Petzer, Andreas L.; Sevelda, Paul; Egle, Daniel; Dubsky, Peter C.; Filipits, Ma... Journal: European journal of cancer Issue: Volume 132(2020) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Influence of Department Volume on Survival for Ovarian Cancer: Results From a Prospective Quality Assurance Program of the Austrian Association for Gynecologic Oncology. Issue 1 (1st January 2009) Authors: Marth, Christian; Hiebl, Sonja; Oberaigner, Willi; Winter, Raimund; Leodolter, Sepp; Sevelda, Paul Journal: International journal of gynecological cancer Issue: Volume 19:Issue 1(2009) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗